Fibrin ( DrugBank: Fibrin )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 279 | Huge venous malformation with cervical, oral and pharyngeal diffuse lesion | 1 |
279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
Clinical trials : 15 / Drugs : 24 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 105
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2100053242 | 2022-06-12 | 2021-11-17 | Clinical study on the safety and efficacy of fibrin glue combined with local injection of pingyangmycin in the treatment of head and neck venous malformations | A prospective, open-label, single-arm, phase II clinical trial to evaluate the efficacy of pingyangmycin combined with fibrin glue in the treatment of head and neck venous malformations | Head and Neck Venous Malformation | Experimental group:Pingyangmycin combined with local injection of fibrin glue; | The First Affiliated Hospital of Sun Yat-Sen University | NULL | Recruiting | 1 | 70 | Both | Experimental group:20; | Phase 2 | China |